FMP

FMP

blog post title

Rivian Shares Slip 2% After Fourth-Quarter Deliveries Miss Expectations

Shares of Rivian Automotive (NASDAQ: RIVN) fell nearly 2% intraday on Friday after the electric vehicle maker reported fourth-quarter delivery figures that came in below Wall Street expectations. T...

blog post title

Telsey Reaffirms Outperform on Costco Ahead of December Sales Update

Telsey Advisory Group reiterated its Outperform rating and $1,100 price target on Costco Wholesale (NASDAQ: COST) ahead ...

blog post title

ASML Shares Surge After Aletheia Double Upgrades Stock to Buy

Shares of ASML (NASDAQ: ASML) jumped more than 8% intraday on Friday after Aletheia Capital double upgraded the stock to...

blog post title

Raymond James Reaffirms Strong Buy on Ardelyx After Drug Price Increases

Raymond James reiterated its Strong Buy rating and $16 price target on Ardelyx (NASDAQ: ARDX) following price increases ...

blog post title

Citizens Raises Alphabet Price Target on Accelerating Search and AI Momentum

Citizens raised its price target on Alphabet (NASDAQ: GOOGL) to $385 from $340 while maintaining a Market Outperform rat...

blog post title

Freedom Capital Initiates Gambling.com Coverage With Buy Rating

Freedom Capital Markets initiated coverage on Gambling.com Group (NASDAQ: GAMB) with a Buy rating and a price target of ...

blog post title

UBS Reiterates Buy on Signet Jewelers After Positive Holiday Sales Signals

UBS reiterated its Buy rating and $115 price target on Signet Jewelers (NYSE: SIG), citing encouraging indications for U...

blog post title

Roth/MKM Reaffirms Buy on Devon Energy After 2026 Production Review

Roth/MKM reiterated a Buy rating and a $42 price target on Devon Energy (NYSE: DVN) after reviewing the company’s 2026 p...

blog post title

Clear Street Upgrades Plug Power to Buy on Improved Risk-Reward

Clear Street upgraded Plug Power (NASDAQ: PLUG) to Buy from Hold while lowering its price target to $3.00 from $3.50, re...

blog post title

BofA Cuts Parsons Target After FAA Contract Loss but Maintains Buy

BofA Securities lowered its price target on Parsons (NYSE: PSN) to $90 from $95 while maintaining a Buy rating, followin...

blog post title

Wells Fargo Reiterates Overweight on NVIDIA After Groq Licensing Clarification

Wells Fargo reiterated its Overweight rating and $265 price target on NVIDIA (NASDAQ: NVDA), following clarification aro...

blog post title

Lake Street Lifts Velo3D Target as Reshoring and Defense Tailwinds Strengthen Case

Lake Street Capital Markets raised its price target on Velo3D (NASDAQ: VELO) to $18 from $6 while maintaining a Buy rati...

blog post title

Bernstein Reaffirms Outperform on Gilead as Medicaid Risk Appears Contained

Bernstein SocGen Group reiterated its Outperform rating and $135 price target on Gilead Sciences (NASDAQ: GILD), citing ...

blog post title

Bernstein Cuts Lamb Weston Target as Profit Outlook Raises 2027 Concerns

Bernstein SocGen Group lowered its price target on Lamb Weston (NYSE: LW) to $46 from $65 while maintaining a Market Per...

blog post title

Clear Street Raises Intuitive Machines Price Target Following Lanteris Acquisition

Clear Street raised its price target on Intuitive Machines (NASDAQ: LUNR) to $25 from $17 while maintaining a Buy rating...

blog post title

MoffettNathanson Reiterates Buy on Datadog After Post-Peak Pullback

MoffettNathanson reiterated a Buy rating and $255 price target on Datadog (NASDAQ: DDOG), arguing that the stock’s recen...

blog post title

BofA Maintains Buy Rating on NVIDIA After Groq Licensing News

BofA Securities reiterated its Buy rating and $275 price target on NVIDIA Corp. (NASDAQ: NVDA), following news that priv...

blog post title

UBS Reaffirms Neutral View on Nike Despite Improving Brand Indicators

UBS reiterated a Neutral rating and a $62 price target on Nike Inc. (NYSE: NKE), citing improving brand momentum but a l...

blog post title

Freedom Capital Initiates MDU Resources Coverage With Hold Rating

Freedom Capital Markets initiated coverage on MDU Resources Group Inc. (NYSE: MDU) with a Hold rating and a $20 price ta...

blog post title

H.C. Wainwright Maintains Neutral Stance on Biohaven After BHV-7000 Setback

H.C. Wainwright reiterated a Neutral rating and $11 price target on Biohaven Pharmaceutical Holding Co. (NYSE: BHVN) fol...